checkAd

     119  0 Kommentare Kura Oncology Announces Commencement of Public Offering of Common Stock - Seite 3

    Contacts

    Company:
    Pete De Spain
    Vice President, Investor Relations &
    Corporate Communications
    (858) 500-8803
    pete@kuraoncology.com

    Investors:
    Robert H. Uhl
    Managing Director
    Westwicke ICR
    (858) 356-5932
    robert.uhl@westwicke.com

    Lesen Sie auch

    Media:
    Jason Spark
    Managing Director
    Canale Communications
    (619) 849-6005
    jason@canalecomm.com


    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Kura Oncology Announces Commencement of Public Offering of Common Stock - Seite 3 SAN DIEGO, May 05, 2020 (GLOBE NEWSWIRE) - Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that it has commenced …